Mark R. Warner sold ZIOPHARM Oncology, Inc. (ZIOP)
Mark R. Warner (D-VA), a U.S. Senator, has disclosed 1 trade in ZIOPHARM Oncology, Inc. (ZIOP) since 2017, a single sale, worth an estimated $375K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Mark R. Warner sold $250,001 - $500,000 of ZIOPHARM Oncology, Inc. (ZIOP) on October 18, 2017. Since that trade, ZIOP is up +0.00% against the S&P 500 up +225.76%, an outperformance of -225.76%.
Data updated
Mark R. Warner's ZIOP trades vs the price
ZIOP is up +0.00% since Mark R. Warner sold on October 18, 2017, versus +225.76% for the S&P 500.
Performance since this trade
All Mark R. Warner ZIOP trades
Mark R. Warner & ZIOP trading FAQ
Is it legal for Mark R. Warner to trade ZIOPHARM Oncology, Inc. (ZIOP) stock?
Yes. Members of Congress are allowed to trade individual stocks, including ZIOPHARM Oncology, Inc. (ZIOP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mark R. Warner sell ZIOP?
Mark R. Warner disclosed a sale of $250,001 - $500,000 of ZIOPHARM Oncology, Inc. (ZIOP) on October 18, 2017, according to public STOCK Act filings.
How has ZIOP performed since Mark R. Warner's trade?
Since Mark R. Warner sold ZIOP on October 18, 2017, the stock is up +0.00%, versus +225.76% for the S&P 500 over the same period, an outperformance of -225.76%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ZIOP trades?
Quantellect tracks every disclosed congressional trade in ZIOPHARM Oncology, Inc. (ZIOP) on the ZIOPHARM Oncology, Inc. congressional trading page, which aggregates filings across all members of Congress.
Mark R. Warner's ZIOP tradesAll congressional filings for ZIOPHARM Oncology, Inc.Mark R. Warner's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.